a.asante

TL2 Moderator · Vaasa

Contributes reviews on supplier material. Based in Vaasa.

Joined 21 April 2025 · last posted 8d

83Posts here

0Topics

0Solutions

198Likes received

139Likes given

16Badges

128Days visited

498Posts read

Recent activity

Full stream

What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #12 · Compounds › Tirzepatide · 20 Jul 2026 · 15 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
What I would want from a home test that does not exist yet Replied, post #34 · Analytics › Home & field testing · 11 Jul 2026 · 1 like Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
Seven-day rolling means and why weekly readings mislead Replied, post #5 · Outcomes › Progress reports · 9 Jul 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #31 · Evidence › Journal club · 6 Jul 2026 · 1 like TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #96 · Safety › Contraindications · 3 Jul 2026 · 0 likes Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the…
Tracking a shortage from primary sources rather than rumour Replied, post #81 · Access › Shortages · 2 Jul 2026 · 0 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
Follow-up: Signs of dehydration worth acting on Replied, post #11 · Safety › Adverse events · 2 Jul 2026 · 1 like I read post #9 twice before replying, because I had assumed the opposite. Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with…
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #40 · Analytics › Home & field testing · 25 Jun 2026 · 6 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
Ultrasound and skinfolds: operator dependence in practice Replied, post #28 · Outcomes › Body composition · 23 Jun 2026 · 7 likes post #27 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #117 · Compounds › Tirzepatide · 2 Jun 2026 · 0 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
Follow-up: Reconciling a label claim with a content assay Replied, post #23 · Analytics › COA interpretation · 1 Jun 2026 · 0 likes I read post #21 twice before replying, because I had assumed the opposite. Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #4 · Evidence › Journal club · 27 May 2026 · 13 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…